What do systematic reviews say?

More and shorter vs hollow fibre filter of the same membrane type

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

More and shorter vs hollow fibre filter of the same membrane type

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

More and shorter vs hollow fibre filter of the same membrane type

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

CVVHD vs CVVH or CVVHDF

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

CVVHDF vs standard CVVH

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 62 participants
  Low

CVVHDF vs standard CVVH

It is very uncertain whether CVVHDF changes death from any cause at day 28 of compared with CVVH (very low certainty).

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  RR 0.68 [0.52, 0.9]
  1 study · 206 participants
  Very low

CVVHDF vs standard CVVH

It is very uncertain whether CVVHDF changes recovery of kidney function compared with CVVH (very low certainty).

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  RR 1.1 [0.86, 1.41]
  1 study · 96 participants
  Very low

CVVHDF vs standard CVVH

The review found no eligible studies for this question.

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pre‐dilution vs post‐dilution (as defined by study investigators)

• Non‐pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 47 participants
  Low

Single component intervention vs control

Single component intervention showed no clear difference in adherence to pharmacotherapy: number of people completing treatment compared with control (low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 0.67 [0.22, 1.99]
  1 study · 55 participants
  Low

Multi‐component intervention vs control

Multi‐component intervention showed no clear difference in adverse events: number of people experiencing adverse events (all… compared with control (low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 1.05 [0.6, 1.85]
  1 study · 192 participants
  Low

Single component intervention vs control

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 212 participants
  Very low

Single component intervention vs control

It is very uncertain whether single component intervention changes hospital service utilisation: number of people admitted to hospital… compared with control (very low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 1.47 [0.75, 2.9]
  1 study · 212 participants
  Very low

Single component intervention vs control

It is very uncertain whether single component intervention changes exacerbations: number of people experiencing exacerbations compared with control (very low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 0.87 [0.51, 1.5]
  2 studies · 267 participants
  Very low

Single component intervention vs control

It is very uncertain whether single component intervention changes adverse events: number of people experiencing adverse events (all… compared with control (very low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 0.92 [0.6, 1.41]
  3 studies · 404 participants
  Very low

Multi‐component intervention vs control

Multi‐component intervention may leads to higher adherence to pharmacotherapy: number of people achieving adherence… compared with control (low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  RR 1.37 [1.18, 1.59]
  4 studies · 446 participants
  Low

Multi‐component intervention vs control

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 374 participants
  Low

Multi‐component intervention vs control

Multi‐component intervention may leads to lower hospital service utilisation: number of people admitted to hospital… compared with control (low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 0.37 [0.22, 0.63]
  2 studies · 877 participants
  Low

Multi‐component intervention vs control

It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing moderate or severe… compared with control (very low certainty).

• Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD) 2021 · Cochrane Headline outcomes only
  OR 0.97 [0.71, 1.31]
  1 study · 734 participants
  Very low

Any anti‐osteoporotic drugs vs placebo

Any anti‐osteoporotic drugs may leads to lower vertebral fracture by radiography compared with placebo (low certainty).

• Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic… 2021 · Cochrane Headline outcomes only
  RR 0.52 [0.39, 0.69]
  5 studies · 9054 participants
  Low